Inside CSL Behring's Privigen Immunoglobulin Production Facility

Processing tanks used in the purification process of producing Privigen liquid intravenous immunoglobulin are tested prior to production in the Privigen plant of CSL Behring, a unit of CSL Ltd., in Melbourne, Australia, on Wednesday, July 2, 2014. CSL is the world's second-biggest maker of blood-derived therapies. Photographer: Carla Gottgens/Bloomberg via Getty Images
Processing tanks used in the purification process of producing Privigen liquid intravenous immunoglobulin are tested prior to production in the Privigen plant of CSL Behring, a unit of CSL Ltd., in Melbourne, Australia, on Wednesday, July 2, 2014. CSL is the world's second-biggest maker of blood-derived therapies. Photographer: Carla Gottgens/Bloomberg via Getty Images
Inside CSL Behring's Privigen Immunoglobulin Production Facility
PURCHASE A LICENCE
How can I use this image?
₹23,000.00
INR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
451794930
Collection:
Bloomberg
Date created:
02 July, 2014
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
AUSTRALIA CSL BEHRING